Stay updated with breaking news from Nasdaq Immx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immix Biopharma, Inc. (NASDAQ:IMMX – Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 316,600 shares, a growth of 19.9% from the February 29th total of 264,100 shares. Based on an average daily trading volume, of 289,400 […]
Immix Biopharma, Inc. (NASDAQ:IMMX – Get Free Report) saw a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 489,900 shares, an increase of 123.2% from the January 15th total of 219,500 shares. Currently, 6.4% of the shares of the stock are sold short. Based […]
LOS ANGELES, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage...
LOS ANGELES, CA, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage...
Dr. Sanchorawala co-authored landmark study of daratumumab (DARZALEX®) in AL Amyloidosis published in The New England Journal of Medicine, 2021 that led to...